[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension]

Med Klin (Munich). 2010 Dec;105(12):916-23. doi: 10.1007/s00063-010-1157-9. Epub 2011 Jan 16.
[Article in German]

Abstract

Patients suffering from severe chronic liver disease, in particular cirrhosis, are at risk for pulmonary complications. The leading clinical symptom is shortness of breath, which can accompany the actual disease as indirect effect because of anemia, faint muscles or ascites. On the other hand, dyspnea can have multiple additive causes in case of accompanying cardial or pulmonary disease. The hepatopulmonary syndrome (HPS) and the portopulmonary hypertension (PoPH) belong to the most relevant pulmonary complications in liver cirrhosis. HPS appears to be more common than PoPH and the presence of either entity increases morbidity and mortality in patients with liver disease. The two diseases have to be strictly distinguished, as they have opposed histological and pathophysiological origin. While the HPS is a dilatative pulmonary- vascular disease, the PoPH is a constrictive or obliterative pulmonary-vascular disease in the context of a liver disease or a portal hypertension. Therefore, these diseases are separate entities also when it comes to diagnostics and therapy.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Algorithms
  • Cross-Sectional Studies
  • Diagnosis, Differential
  • Dyspnea / etiology
  • Hepatopulmonary Syndrome / diagnosis*
  • Hepatopulmonary Syndrome / epidemiology
  • Hepatopulmonary Syndrome / therapy
  • Humans
  • Hypertension, Portal / diagnosis*
  • Hypertension, Portal / epidemiology
  • Hypertension, Portal / therapy
  • Hypertension, Pulmonary / diagnosis*
  • Hypertension, Pulmonary / epidemiology
  • Hypertension, Pulmonary / therapy
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / epidemiology
  • Liver Cirrhosis / therapy
  • Prognosis
  • Risk Factors